Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMFORT study
2010-018665-30Phase 2Terminated
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of olanzapine and metoclopramide in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: Clinical response rate within 3 days. Started Apr 2010; status: terminated.
02
Drugs
olanzapinemetoclopramide
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2010-018665-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018665-30.